v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities    
Net loss $ (52,418,759) $ (27,374,817)
Net loss from discontinued operations 0 (1,373,457)
Net loss from continuing operations (52,418,759) (26,001,360)
Adjustments to reconcile net loss to net cash used in operations:    
Stock based compensation 7,255,420 3,041,217
Amortization of intangible assets 1,158,270 571,099
Depreciation 495,440 640,342
Deferred income taxes 694,562 0
Payments of taxes related to equity transactions 0 (580,955)
Gain on divestiture of consumer segment 0 (9,642,428)
Impairment on equity method investment 0 11,353,875
Equity method loss 0 1,237,768
Impairment on goodwill and intangible assets 0 506,049
Loss on sale of equity method investment and note receivable 0 4,008,357
Convertible notes payable fair value adjustment 12,939,387 0
Gain on extinguishment of convertible notes payable (2,448,328) 0
Changes in operating assets and liabilities, net of acquisitions    
Accounts receivable (5,617,635) 167,487
Inventory (9,691,110) 548,769
Prepaid inventory (7,311,657) 1,243,974
Prepaid expenses and other current and long-term assets (3,988,130) (1,165,521)
Operating lease right-of-use assets and liabilities 157,430 (64,480)
Contract liabilities and deposits 240,430 (19,746)
Accounts payable 925,317 (840,865)
Accrued expenses 4,952,683 303,652
Net cash used in operating activities of continuing operations (52,656,680) (14,692,766)
Cash Flows from Investing Activities    
Proceeds from divestiture of consumer segment 0 1,000,000
Proceeds from sale of equity method investment and note receivable 0 4,400,000
Purchases of property and equipment (1,249,217) (149,686)
Net cash (used in) provided by investing activities of continuing operations (1,249,217) 5,250,314
Cash Flows from Financing Activities    
Proceeds from issuance of common stock through public offerings 249,248,908 0
Payment of costs related to public offerings (14,900,402) 0
Proceeds from issuance of convertible notes payable 15,000,000 0
Debt issuance costs (567,121) 0
Payments of convertible notes payable (1,650,000) 0
Proceeds from exercise of stock options 1,460,211 0
Proceeds from exercise of warrants 2,586,000 0
Payments under debt obligations 0 (588,003)
Net cash provided by (used in) financing activities of continuing operations 251,177,596 (588,003)
Discontinued operations    
Operating activities 0 (74,556)
Investing activities 0 0
Financing activities 0 (120,413)
Net cash used in discontinued operations 0 (194,969)
Net increase (decrease) in Cash 197,271,699 (10,225,424)
Cash, beginning of period 9,154,297 10,245,064
Cash, end of period 206,425,996 19,640
Cash paid for interest 0 29,498
Cash paid for income taxes 0 0
Non-cash transactions    
Conversion of convertible notes into common stock 12,371,266 0
Equity method investment from divestiture of consumer segment 0 17,000,000
Fair value of shares issued in acquisition 0 7,000,000
Acquisition consideration payable 0 7,000,000
Note receivable from divestiture of consumer segment 0 4,000,000
Net assets assumed in acquisition $ 0 $ 31,435

Source